EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanomedicine applications for the treatment of Staphylococcus aureus infections

Harita Yedavally, Jan Maarten van Dijl iD, Anna Salvati iD

FEMS Microbiology Reviews · 2026

DOI: 10.1093/femsre/fuaf068 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift FEMS Microbiology Reviews, 2026. Verfasst von Harita Yedavally und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nanomedicine and Drug Targeting, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands. Hauptthemen laut MEDLINE: Nanomedicine, Staphylococcal Infections, Anti-Bacterial Agents, Staphylococcus aureus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE Marie Sklodowska-Curie Actions.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus aureus is a Gram-positive bacterium capable of infecting multiple types of cells, organs, and tissues in the human body. Treatment can become highly challenging, especially in the case of intracellular infections and upon biofilm formation. Additionally, this pathogen has developed several antimicrobial resistance mechanisms, and resistant strains such as methicillin-resistant S. aureus (MRSA) are among the most difficult to treat. Within this context, nanomedicine can offer novel and more efficient treatments against S. aureus. Here, we first introduce the challenges in the treatment of S. aureus infections, focusing on intracellular infections and biofilms, and challenges associated with the development of resistance. We then provide an overview of the multiple applications of nanomedicine against S. aureus infection and discuss how nanomedicine may overcome the challenges in reaching this pathogen and eliminating it, including potential solutions less prone to generating resistance. Finally, we discuss the current clinical development of antimicrobial nanomedicines, where only one out of 35 completed trials has so far targeted MRSA, indicating that most research is still at the preclinical stage. Challenges in the clinical translation of antimicrobial nanomedicines are discussed, together with strategies to support the development of these promising therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanomedicineStaphylococcal InfectionsAnti-Bacterial AgentsStaphylococcus aureusHumansBiofilmsMethicillin-Resistant Staphylococcus aureusAnimals

Stichwörter der Autor:innen

Staphylococcus aureusantimicrobial resistancebiofilmsdrug deliveryintracellular infectionsnanomedicine

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Nanomedicine and Drug Targeting, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands.
  • University Medical Center Groningen, Department of Medical Microbiology, University of Groningen, 9713 AV Groningen, The Netherlands.

ORCID-Profile: Jan Maarten van Dijl, Anna Salvati

Förderung

  • HORIZON EUROPE Marie Sklodowska-Curie Actions

Zitieren

APA

Yedavally, H., van Dijl, J. M., & Salvati, A. (2026). Nanomedicine applications for the treatment of Staphylococcus aureus infections. FEMS Microbiology Reviews. https://doi.org/10.1093/femsre/fuaf068

Vancouver

Yedavally H, van Dijl JM, Salvati A. Nanomedicine applications for the treatment of Staphylococcus aureus infections. FEMS Microbiology Reviews. 2026. doi:10.1093/femsre/fuaf068

BibTeX
@article{Yedavally2026,
  author = {Yedavally, Harita and van Dijl, Jan Maarten and Salvati, Anna},
  title = {Nanomedicine applications for the treatment of Staphylococcus aureus infections},
  journal = {FEMS Microbiology Reviews},
  year = {2026},
  doi = {10.1093/femsre/fuaf068}
}
Kostenlos starten →